What is the significance of TP53 accumulation in anal squamous carcinoma?

被引：0
|
作者：
Patel, HS
Northover, JM
Silver, A
机构：
来源：
DISEASES OF THE COLON & RECTUM | 2006年 / 49卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：779 / 780
页数：2
相关论文
共 50 条
  • [21] TP53 codon 72 polymorphism in oral squamous cell carcinoma.
    Drummond, SN
    De Marco, L
    Pordeus, IA
    Barbosa, AA
    Gomez, RS
    JOURNAL OF DENTAL RESEARCH, 2003, 82 : 131 - 131
  • [22] Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran
    Sepehr, A
    Tanière, P
    Martel-Planche, G
    Zia'ee, AA
    Rastgar-Jazii, F
    Yazdanbod, M
    Etemad-Moghadam, G
    Kamangar, F
    Saidi, F
    Hainaut, P
    ONCOGENE, 2001, 20 (50) : 7368 - 7374
  • [23] Clinical significance of TP53 mutation in myeloma
    Chng, W. J.
    Price-Troska, T.
    Gonzalez-Paz, N.
    Van Wier, S.
    Jacobus, S.
    Blood, E.
    Henderson, K.
    Oken, M.
    Van Ness, B.
    Greipp, P.
    Rajkumar, S. V.
    Fonseca, R.
    LEUKEMIA, 2007, 21 (03) : 582 - 584
  • [24] Association between TP53 gene deletion and protein expression in esophageal squamous cell carcinoma and its prognostic significance
    Niyaz, Madiniyet
    Ainiwaer, Julaiti
    Abudureheman, Abulajiang
    Zhang, Liwei
    Sheyhidin, Ilyar
    Turhong, Abduheny
    Cai, Ren
    Hou, Zhichao
    Awut, Edris
    ONCOLOGY LETTERS, 2020, 20 (02) : 1855 - 1865
  • [25] Evaluation of computational tools to determine prognostic significance of TP53 mutation in head and neck squamous cell carcinoma (HNSCC)
    Masica, David
    Li, Shuli
    Douville, Chris
    Manola, Judith
    Ferris, Robert L.
    Burtness, Barbara
    Forastiere, Arlene A.
    Koch, Wayne
    Karchin, Rachel
    Chung, Christine H.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] Clinical significance of TP53 mutation in myeloma
    W J Chng
    T Price-Troska
    N Gonzalez-Paz
    S Van Wier
    S Jacobus
    E Blood
    K Henderson
    M Oken
    B Van Ness
    P Greipp
    S V Rajkumar
    R Fonseca
    Leukemia, 2007, 21 : 582 - 584
  • [27] HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53
    D Meulendijks
    N B Tomasoa
    L Dewit
    P H M Smits
    R Bakker
    M-L F van Velthuysen
    E H Rosenberg
    J H Beijnen
    J H M Schellens
    A Cats
    British Journal of Cancer, 2015, 112 : 1358 - 1366
  • [28] Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status
    Zhu, Xiaoqin
    Jamshed, Sarah
    Zou, Jian
    Azar, Azniv
    Meng, Xiuling
    Bathini, Venu
    Dresser, Karen
    Strock, Cara
    Yalamarti, Bhargavi
    Yang, Michelle
    Tomaszewicz, Keith
    Tjionas, George
    Mochel, Mark C.
    Hutchinson, Lloyd
    Bledsoe, Jacob R.
    MODERN PATHOLOGY, 2021, 34 (05) : 1017 - 1030
  • [29] HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53
    Meulendijks, D. M
    Tomasoa, N. B.
    Dewit, L.
    Smits, P. H. M.
    Bakker, R.
    van Velthuysen, M-L F.
    Rosenberg, E. H.
    Beijnen, J. H.
    Schellens, J. H. M.
    Cats, A.
    BRITISH JOURNAL OF CANCER, 2015, 112 (08) : 1358 - 1366
  • [30] Predicting survival in head and neck squamous cell carcinoma from TP53 mutation
    David L. Masica
    Shuli Li
    Christopher Douville
    Judith Manola
    Robert L. Ferris
    Barbara Burtness
    Arlene A. Forastiere
    Wayne M. Koch
    Christine H. Chung
    Rachel Karchin
    Human Genetics, 2015, 134 : 497 - 507
12345